Piramal acquires Caladryl from Valeant Pharma

Piramal Enterprises Ltd. (formerly Piramal Healthcare Ltd.) has acquired over-the-counter (OTC) brand Caladryl in India from Valeant Pharmaceuticals International, Inc. for an unspecified amount.

Caladryl is an anti-pruritic solution known for dermatosis application for minor skin irritations and itching.

Valeant Pharmaceuticals had acquired the rights to the Caladryl brand from Johnson & Johnson in 2012.

This acquisition enables Piramal Enterprises to widen its consumer products portfolio in the skin care segment, the company.

The company covers more than 1,00,000 towns in the country.